Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortImmunosuppressant for transplants and lupus kidney disease.Anti-rejection medicine after transplants.
Body systemJoints & ImmunityJoints & Immunity
Drug classAntiproliferative immunosuppressantsCalcineurin inhibitors
SupplyPrescription onlyPrescription only
Main usesKidney, liver and heart transplants, Lupus nephritis, Vasculitis and other autoimmune diseasesPreventing transplant rejection, Eczema (ointment), Lupus nephritis (specialist)
How it worksStops immune cells multiplying.Stops immune cells attacking a transplanted organ.
Starts working——
Half-lifeAbout 18 hoursAbout 12 hours (variable)
Typical adult doseCommonly 1–1.5 g twice a day (mofetil).Weight-based starting doses, then adjusted to trough blood levels.
FormsTablet, Capsule, Oral suspension, IV infusion, Gastro-resistant tabletCapsule, Modified-release capsule, Granules, Injection, Ointment
Common side effectsDiarrhoea, Nausea, Low white cellsTremor, Headache, High blood pressure, High blood sugar
Serious side effectsSerious infections, Birth defects and miscarriage, Lymphoma and skin cancer, PML (rare brain infection)Kidney damage, Infections, Skin cancer and lymphoma, Diabetes
Don't take if——
Alcohol——
PregnancyUsually avoidedContraindicated — high rate of birth defects.Use with cautionContinued after transplant with specialist care.
Breastfeeding——
In use since19951994
Brand namesUnited States: CellCept, MyforticUnited Kingdom: CellCept, Myfenax, MyforticIndia: Mycept, CellmuneUnited States: Prograf, Envarsus XR, ProtopicUnited Kingdom: Prograf, Advagraf, Adoport, ProtopicIndia: Pangraf, Tacrograf
Legal status——
ATC codeL04AA06L04AD02

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker